What's breaking now, across thousands of outlets.
Revolution Medicines’ brand-new treatment brought in far higher sales than expected in its first few weeks on the market.
We haven't written up this one. MarketWatch has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
The projected saving will apply to patients who receive certain outpatient medications covered by Medicare.
Franklin Cudjoe, Founding President and CEO of IMANI Centre for Policy and Education, has undergone surgery at RUSH University Medical Center in Chicago. In a message ahead of the procedure, Mr.
In this Point of View Anthony Blaszczyk, PhD, principal scientist at USP provides insights on how delivery technologies will shape the future of cell and gene therapy.
Picture a young person who walks out of my office with a new ADHD diagnosis and feels relief. There is finally a name for years of missed deadlines and unfinished paperwork.
Researchers studying the winter 2022/2023 outbreak of group A streptococcus infections in Scotland have found strong evidence that the outbreak was not caused by a new virulent strain of the bacteria…
Wall Street analysts are already resetting projections for Rasonque — but company executives cautioned that it’s too early to draw conclusions about the pancreatic cancer drug’s launch trajectory.
